Autologous bone marrow transplantation in 44 patients with aggressive non-Hodgkin's lymphoma at University 'La Sapienza' of Rome

Leukemia and Lymphoma

Volumn 23, Issue 1-2, 1996, Pages 147-151

  Capria, Saveria ^a   Vignetti, Marco ^a   Proia, Anna ^a   Caruso, Roberta ^a   Coppola, Lorenzo ^a   Orsini, Enrica ^a   Meloni, Giovanna ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

High dose chemotherapy; NHL; Partial remission; Sensitive relapse

Indexed keywords

ANTIBIOTIC AGENT; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HUMAN; INFECTION; MALE; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0029804098     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054814     Document Type: Article

References (17)

1. Devita, V. T., Hubbard, S. M., Young, R. C. and Longo, D. L. (1988) The role of chemotherapy in diffuse aggressive lymphoma. Semin. Hematol., 25(2), 2-10.
2. Cabanillas, F., Hagemeister, F. B., Bodey, G. P. and Freirich, E. J. (1982) IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. Blood. 60, 693-697.
3. Velasquez, W. S., Swan, F., Redman, J., et al. (1989) Combination of etoposide, high dose ARA-C and solumedrol with or without platinol in relapsing or resistant lymphoma. In Proceedings of ASCO, 8, 256.
4. Petersen, F. B., Appelbaum, F. R., Hill, R et al. (1990) Autologous marrow transplant for malignant lymphoma: a report of 101 cases from Seattle. J Clin. Oncol., 8, 638-647.
5. Philip, T., Armitage, J., Spitzer, G. et al. (1987) High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade and high grade non-Hodgkin lymphoma. New Engl J. Med., 316, 1493-1498.
6. Takvorian, T., Canellos, G., Ritz, J. et al. (1987) Prolonged disease free survival after autologous bone marrow transplantation in patients with non Hodgkin's lymphoma with a poor prognosis. New. Engl. J. Med., 316, 1499-1505.
7. Meloni, G., De Fabritiis, P., Papa, G. et al. (1985) Cryopreserved autologous bone marrow infusion following high dose chemotherapy in patients with acute myeloblastic leukemia in first relapse. Leuk. Res., 9, 407.
8. Philip, T., Chauvin, F., Armitage, J. et al. (1991) Parma International Protocol: Pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation. Blood, 77(7), 1587-1592.
9. Tutschka, P. J., Copelan, E A. and Klein, J. P. (1987) Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood, 70, 1382.
10. Cabanillas, F., Hagemeister, F. B., McLaughlin, P. et al. (1987) Results of MIME salvage regimen for recurrent or refractory lymphoma. J. Clin. Oncol., 5(3), 407-412.
11. Velasquez, W. S., Cabanillas, F., Salvadore, P et al (1988) Effective salvage therapy for lymphoma with cisplatin in combination with high dose ARA-C and dexamethasone (DHAP). Blood, 71, 117
12. Goldstone, A. H., McMillan, A. K. and Chopra, R. (1992) High dose therapy for the treatment of non Hodgkin' s lymphoma. In High dose cancer therapy: Pharmacology, Hematopoietins, stem cells. Edited by Armitage J. O , Antman, K. H., pp 662-676. Baltimore: Williams and Wilkins.
13. Guglielmi, C., Chauvin, F., HagenbeeK, A. et al. (1993) The Parma International randomized prospective study in relapsed non Hodgkin lymphoma: second interim analysis of 172 patients and update. In Proceedings of the Fifth International Conference on Malignant Lymphoma (Lugano 1993), Abs. 92.
14. Haioun, C., Lepage, E., Gisselbrecht, G. et al. (1993) Autologous bone marrow transplantation versus sequential chemotherapy in first complete remission aggressive non Hodgkin's lymphoma. In Proceedings of the Fifth International Conference on Malygnant Lymphoma (Lugano, Switzerland), p 41, Abstr. 48.
15. Tura, S., Zinzani, P. L., Mazza, P. et al. (1992) ABMT vs DHAP in residual disease following third generation regimens for aggressive non Hodgkin's lymphoma. Blood, 80(1), 157 (abstr. 619).
16. Verdonck, L. F., Van Putten, W. L. J., Hagenbeek, A. et al. (1995) Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N. Engl. J. Med., 332, 1045-1051.
17. Gianni, A. M., Bregni, M., Siena, S. et al. (1994) 5-year update of the Milan Cancer Institute randomized trial of high-dose sequential (HDS) vs MACOP-B therapy for diffuse large-cell lymphomas In Proceedings of conferenza CNR P.F. ACRO "La Ricerca Oncologica in Italia" (Roma, 9-10 June 1994), edited by CNR-Roma, p. 459.